InMed Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

InMed Pharmaceuticals

23/09/2022 20:24

* InMed Pharmaceuticals Inc  INM.OQ  reported a quarterly
adjusted
loss of $14.03​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of $5.50
per share.
    * Revenue was $520.00 thousand​; analysts expected $750.00
thousand. 
    * InMed Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $14.03​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * InMed Pharmaceuticals Inc shares had fallen by 41.2% this
quarter and lost 78.9% so far this year.
    * The company reported a quarterly loss of $7.87 million.
    * Wall Street's median 12-month price target for InMed
Pharmaceuticals Inc is $20.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data September
23 at 07:24 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -5.50          -14.03         Missed
 Mar. 31 2022      -6.25          -6.25          Met
 Dec. 31 2021      -5.87          -7.75          Missed
 Sep. 30 2021      -8.75          -6.25          Beat